Premium Information is available for this item - Upgrade for $1 a day
6505-01-280-1793
And Magnesium Hydroxide Tablets Calcium Carbonate Dried Aluminum Hydroxide Gel Aspirin
6505012801793 012801793 ASCRIPTIN NDC00067-0145-72 013572
INC: 40754 And Magnesium Hydroxide Tablets Calcium Carbonate Dried Aluminum Hydroxide Gel Aspirin
January 2023
5
Marketplace 6505-01-280-1793
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-280-1793 5+ Documents (More...)
Changed Changed Changed Changed 012801793 6505012801793012801793,ASCRIPTIN 1P132-013572 Documents (
6505012801793012801793,ASCRIPTIN Carbonate Dried Aluminum Hydroxide Gel Aspirin6505012801793 012801793
6505012801793 012801793,ASCRIPTIN Carbonate Dried Aluminum Hydroxide Gel Aspirin6505012801793 012801793
ASCRIPTIN NDC00067-0145-72 013572 your web browser . 6240-14-505-7628Incandescent Lamp6240145057628
JavaScript in your web browser . 7030-15-230-1847Progr.Autom.Su Disc7030152301847 152301847 1P132-013572
JavaScript in your web browser . 7030-15-230-1847Progr.Autom.Su Disc7030152301847 152301847 1P132-013572
6505012801793 012801793,ASCRIPTIN 1P132-013572 JavaScript in your web browser . 7030-15-230-1847Progr.Autom.Su
Disc7030152301847 152301847 1P132-013572 https//www.nsnlookup.com /fsg-70/fsc-7030/it 7030-15-230-1847
6505012801793 012801793,ASCRIPTIN Disc 7030152301847152301847 JavaScript in your https//www.nsnlookup.com
Upgrade your Account Upgrade 4730-01-096-9137Tube Reducer4730010969137 010969137NW171927911M7911 013572
Restrictions 6505-01-280-1793
6505-01-280-1793 is a And Magnesium Hydroxide Tablets Calcium Carbonate Dried Aluminum Hydroxide Gel Aspirin that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-280-1793
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-280-1793
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-280-1793
- Part Number
- Manufacturer
- Status
- NDC00067-0145-72
- Manufacturer
- 04518 - Aventis Pharmaceuticals Products (Active)
- Primary Buy
- Primary Buy
- 013572
- 04518 - Aventis Pharmaceuticals Products (Active)
- Primary Buy
- Primary Buy
- ASCRIPTIN
- 04518 - Aventis Pharmaceuticals Products (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-280-1793
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Aluminum Hydroxide Gel, Dried Active Ingredient And 50.000 Milligrams Magnesium Hydroxide Active Ingredient And 87.000 Milligrams Calcium Carbonate Active Ingredient And 325.000 Milligrams Aspirin Active Ingredient
- Primary Container Content Quantity [CRLK]
- 2.000 Tablets
- Special Features [FEAT]
- Primary Container Type:Packet;
- Total Primary Container Quantity [CSCW]
- 250
Similar Supply Items to 6505-01-280-1793
Freight Information 6505-01-280-1793
6505-01-280-1793 has freight characteristics.. 6505-01-280-1793 has a variance between NMFC and UFC when transported by rail and the description should be consulted.